2021-09-11

According to the official report of btyc blockchain fund of Singapore, the EC technical team has realized the integration of EC blockchain + ERP system to enable the enterprise. The purpose is to reasonably allocate all aspects of resources (including marketing, finance, supply, material, production and other factors) of the traditional enterprise, reduce the cost in all aspects, so as to give full play to its efficiency and enable the enterprise to give full play to its energy in the fierce market competition, So as to obtain the best economic benefits.
According to the official report of btyc blockchain fund of Singapore, the EC technical team has realized the integration of EC blockchain + ERP system to enable the enterprise. The purpose is to reasonably allocate all aspects of resources (including marketing, finance, supply, material, production and other factors) of the traditional enterprise, reduce the cost in all aspects, so as to give full play to its efficiency and enable the enterprise to give full play to its energy in the fierce market competition, So as to obtain the best economic benefits. The ec-fil cross chain bridge was independently developed by the EC technical team in September 2020. It uses the EC expected consensus mechanism to store data distributed cross chain slices based on filecoin high-capacity nodes. In the future, coin.ec users will bridge Web 3.0 through the decentralized storage scheme provided by ecfil, Through ecfil cross chain bridge, decentralized distributed mass storage is realized for the data of coin.ec enterprise users.
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map